Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders.
Louise C F CoppinFrançoise SmetsJérome AmbroiseEtienne E M SokalXavier StéphennePublished in: Stem cell research & therapy (2020)
ClinicalTrials.gov identifier: NCT01765283-January 10, 2013.